25 XP   0   0   10

Biotest Aktiengesellschaft
Buy, Hold or Sell?

Let's analyse Biotest Aktiengesellschaft together

PenkeI guess you are interested in Biotest Aktiengesellschaft. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Biotest Aktiengesellschaft. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Biotest Aktiengesellschaft

I send you an email if I find something interesting about Biotest Aktiengesellschaft.

Quick analysis of Biotest Aktiengesellschaft (30 sec.)










What can you expect buying and holding a share of Biotest Aktiengesellschaft? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
85.7%

What is your share worth?

Current worth
€12.61
Expected worth in 1 year
€25.53
How sure are you?
42.9%

+ What do you gain per year?

Total Gains per Share
€12.92
Return On Investment
31.2%

For what price can you sell your share?

Current Price per Share
€41.40
Expected price per share
€41.00 - €41.40
How sure are you?
50%

1. Valuation of Biotest Aktiengesellschaft (5 min.)




Live pricePrice per Share (EOD)

€41.40

Intrinsic Value Per Share

€-5.13 - €9.04

Total Value Per Share

€7.47 - €21.65

2. Growth of Biotest Aktiengesellschaft (5 min.)




Is Biotest Aktiengesellschaft growing?

Current yearPrevious yearGrowGrow %
How rich?$533.8m$397m$136.7m25.6%

How much money is Biotest Aktiengesellschaft making?

Current yearPrevious yearGrowGrow %
Making money$135.8m-$33.9m$169.8m125.0%
Net Profit Margin18.6%-6.1%--

How much money comes from the company's main activities?

3. Financial Health of Biotest Aktiengesellschaft (5 min.)




4. Comparing to competitors in the Other industry (5 min.)




  Industry Rankings (Other)  


Richest
#103 / 394

Most Revenue
#175 / 394

Most Profit
#103 / 394

What can you expect buying and holding a share of Biotest Aktiengesellschaft? (5 min.)

Welcome investor! Biotest Aktiengesellschaft's management wants to use your money to grow the business. In return you get a share of Biotest Aktiengesellschaft.

What can you expect buying and holding a share of Biotest Aktiengesellschaft?

First you should know what it really means to hold a share of Biotest Aktiengesellschaft. And how you can make/lose money.

Speculation

The Price per Share of Biotest Aktiengesellschaft is €41.40. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Biotest Aktiengesellschaft.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Biotest Aktiengesellschaft, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €12.61. Based on the TTM, the Book Value Change Per Share is €3.23 per quarter. Based on the YOY, the Book Value Change Per Share is €-0.24 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Biotest Aktiengesellschaft.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps3.438.3%3.438.3%-0.86-2.1%-0.02-0.1%0.591.4%
Usd Book Value Change Per Share3.468.3%3.468.3%-0.25-0.6%0.020.0%1.934.7%
Usd Dividend Per Share0.000.0%0.000.0%0.020.1%0.020.0%0.020.1%
Usd Total Gains Per Share3.468.3%3.468.3%-0.23-0.6%0.040.1%1.954.7%
Usd Price Per Share45.58-45.58-45.58-37.89-32.35-
Price to Earnings Ratio13.27-13.27--53.18--53.28--65.18-
Price-to-Total Gains Ratio13.19-13.19--198.32--58.20--40.21-
Price to Book Ratio3.38-3.38-4.54-3.33-2.66-
Price-to-Total Gains Ratio13.19-13.19--198.32--58.20--40.21-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share44.298
Number of shares22
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.02
Usd Book Value Change Per Share3.460.02
Usd Total Gains Per Share3.460.04
Gains per Quarter (22 shares)76.020.82
Gains per Year (22 shares)304.103.28
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1030429422-7
2060859834-4
3091290255-1
4012161206672
5015201510895
60182518149118
7021292118111211
8024332422121414
9027372726141617
10030413030151820

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%1.02.00.033.3%1.04.00.020.0%2.05.00.028.6%2.05.00.028.6%
Book Value Change Per Share1.00.00.0100.0%1.02.00.033.3%1.04.00.020.0%3.04.00.042.9%3.04.00.042.9%
Dividend per Share0.00.01.00.0%2.00.01.066.7%4.00.01.080.0%6.00.01.085.7%6.00.01.085.7%
Total Gains per Share1.00.00.0100.0%1.02.00.033.3%1.04.00.020.0%3.04.00.042.9%3.04.00.042.9%

Fundamentals of Biotest Aktiengesellschaft

About Biotest Aktiengesellschaft

  • Other
  • 0

There is no Profile data available for BIO.BE.

Fundamental data was last updated by Penke on 2024-04-09 09:44:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is very efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Biotest Aktiengesellschaft.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Biotest Aktiengesellschaft earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Biotest Aktiengesellschaft to the Other industry mean.
  • A Net Profit Margin of 18.6% means that €0.19 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Biotest Aktiengesellschaft:

  • The MRQ is 18.6%. The company is making a huge profit. +2
  • The TTM is 18.6%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ18.6%TTM18.6%0.0%
TTM18.6%YOY-6.1%+24.7%
TTM18.6%5Y-1.5%+20.0%
5Y-1.5%10Y3.6%-5.1%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ18.6%5.6%+13.0%
TTM18.6%5.4%+13.2%
YOY-6.1%6.9%-13.0%
5Y-1.5%6.1%-7.6%
10Y3.6%6.1%-2.5%
1.1.2. Return on Assets

Shows how efficient Biotest Aktiengesellschaft is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Biotest Aktiengesellschaft to the Other industry mean.
  • 9.0% Return on Assets means that Biotest Aktiengesellschaft generated €0.09 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Biotest Aktiengesellschaft:

  • The MRQ is 9.0%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 9.0%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ9.0%TTM9.0%0.0%
TTM9.0%YOY-2.6%+11.6%
TTM9.0%5Y-0.5%+9.5%
5Y-0.5%10Y1.2%-1.7%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ9.0%1.0%+8.0%
TTM9.0%1.0%+8.0%
YOY-2.6%1.5%-4.1%
5Y-0.5%1.2%-1.7%
10Y1.2%1.4%-0.2%
1.1.3. Return on Equity

Shows how efficient Biotest Aktiengesellschaft is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Biotest Aktiengesellschaft to the Other industry mean.
  • 25.5% Return on Equity means Biotest Aktiengesellschaft generated €0.25 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Biotest Aktiengesellschaft:

  • The MRQ is 25.5%. Using its investors money, the company is very efficient in making profit. +2
  • The TTM is 25.5%. Using its investors money, the company is very efficient in making profit. +2
Trends
Current periodCompared to+/- 
MRQ25.5%TTM25.5%0.0%
TTM25.5%YOY-8.5%+34.0%
TTM25.5%5Y-1.6%+27.0%
5Y-1.6%10Y1.9%-3.5%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ25.5%3.2%+22.3%
TTM25.5%3.3%+22.2%
YOY-8.5%4.9%-13.4%
5Y-1.6%3.8%-5.4%
10Y1.9%3.8%-1.9%

1.2. Operating Efficiency of Biotest Aktiengesellschaft.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Biotest Aktiengesellschaft is operating .

  • Measures how much profit Biotest Aktiengesellschaft makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Biotest Aktiengesellschaft to the Other industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Biotest Aktiengesellschaft:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y2.5%-2.5%
5Y2.5%10Y4.7%-2.1%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ-10.7%-10.7%
TTM-9.8%-9.8%
YOY-8.9%-8.9%
5Y2.5%6.0%-3.5%
10Y4.7%7.2%-2.5%
1.2.2. Operating Ratio

Measures how efficient Biotest Aktiengesellschaft is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Other industry mean).
  • An Operation Ratio of 1.42 means that the operating costs are €1.42 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Biotest Aktiengesellschaft:

  • The MRQ is 1.415. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.415. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.415TTM1.4150.000
TTM1.415YOY1.774-0.359
TTM1.4155Y1.716-0.301
5Y1.71610Y1.689+0.027
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4151.249+0.166
TTM1.4151.260+0.155
YOY1.7741.216+0.558
5Y1.7161.257+0.459
10Y1.6891.355+0.334

1.3. Liquidity of Biotest Aktiengesellschaft.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Biotest Aktiengesellschaft is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Other industry mean).
  • A Current Ratio of 1.96 means the company has €1.96 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Biotest Aktiengesellschaft:

  • The MRQ is 1.963. The company is able to pay all its short-term debts. +1
  • The TTM is 1.963. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.963TTM1.9630.000
TTM1.963YOY4.757-2.794
TTM1.9635Y4.289-2.325
5Y4.28910Y3.797+0.492
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ1.9631.436+0.527
TTM1.9631.515+0.448
YOY4.7571.526+3.231
5Y4.2891.478+2.811
10Y3.7971.478+2.319
1.3.2. Quick Ratio

Measures if Biotest Aktiengesellschaft is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Biotest Aktiengesellschaft to the Other industry mean.
  • A Quick Ratio of 0.40 means the company can pay off €0.40 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Biotest Aktiengesellschaft:

  • The MRQ is 0.404. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.404. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.404TTM0.4040.000
TTM0.404YOY1.110-0.706
TTM0.4045Y1.013-0.609
5Y1.01310Y1.013-0.001
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4040.566-0.162
TTM0.4040.604-0.200
YOY1.1100.606+0.504
5Y1.0130.608+0.405
10Y1.0130.603+0.410

1.4. Solvency of Biotest Aktiengesellschaft.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Biotest Aktiengesellschaft assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Biotest Aktiengesellschaft to Other industry mean.
  • A Debt to Asset Ratio of 0.65 means that Biotest Aktiengesellschaft assets are financed with 64.6% credit (debt) and the remaining percentage (100% - 64.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Biotest Aktiengesellschaft:

  • The MRQ is 0.646. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.646. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.646TTM0.6460.000
TTM0.646YOY0.692-0.045
TTM0.6465Y0.635+0.012
5Y0.63510Y0.619+0.015
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6460.531+0.115
TTM0.6460.535+0.111
YOY0.6920.551+0.141
5Y0.6350.567+0.068
10Y0.6190.572+0.047
1.4.2. Debt to Equity Ratio

Measures if Biotest Aktiengesellschaft is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Biotest Aktiengesellschaft to the Other industry mean.
  • A Debt to Equity ratio of 182.8% means that company has €1.83 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Biotest Aktiengesellschaft:

  • The MRQ is 1.828. The company is just able to pay all its debts with equity.
  • The TTM is 1.828. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ1.828TTM1.8280.000
TTM1.828YOY2.242-0.414
TTM1.8285Y1.772+0.056
5Y1.77210Y1.671+0.101
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ1.8281.105+0.723
TTM1.8281.100+0.728
YOY2.2421.186+1.056
5Y1.7721.327+0.445
10Y1.6711.473+0.198

2. Market Valuation of Biotest Aktiengesellschaft

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Biotest Aktiengesellschaft generates.

  • Above 15 is considered overpriced but always compare Biotest Aktiengesellschaft to the Other industry mean.
  • A PE ratio of 13.27 means the investor is paying €13.27 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Biotest Aktiengesellschaft:

  • The EOD is 12.900. Based on the earnings, the company is underpriced. +1
  • The MRQ is 13.274. Based on the earnings, the company is underpriced. +1
  • The TTM is 13.274. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD12.900MRQ13.274-0.374
MRQ13.274TTM13.2740.000
TTM13.274YOY-53.178+66.452
TTM13.2745Y-53.275+66.549
5Y-53.27510Y-65.182+11.907
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
EOD12.90013.243-0.343
MRQ13.27410.893+2.381
TTM13.27410.521+2.753
YOY-53.17811.319-64.497
5Y-53.27512.391-65.666
10Y-65.18212.665-77.847
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Biotest Aktiengesellschaft:

  • The EOD is -45.381. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -46.697. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -46.697. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-45.381MRQ-46.697+1.315
MRQ-46.697TTM-46.6970.000
TTM-46.697YOY-24.151-22.545
TTM-46.6975Y-0.379-46.318
5Y-0.37910Y-3.027+2.648
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
EOD-45.3814.283-49.664
MRQ-46.6973.977-50.674
TTM-46.6975.128-51.825
YOY-24.1511.969-26.120
5Y-0.3791.965-2.344
10Y-3.0273.382-6.409
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Biotest Aktiengesellschaft is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Other industry mean).
  • A PB ratio of 3.38 means the investor is paying €3.38 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Biotest Aktiengesellschaft:

  • The EOD is 3.284. Based on the equity, the company is fair priced.
  • The MRQ is 3.379. Based on the equity, the company is fair priced.
  • The TTM is 3.379. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD3.284MRQ3.379-0.095
MRQ3.379TTM3.3790.000
TTM3.379YOY4.543-1.164
TTM3.3795Y3.328+0.051
5Y3.32810Y2.663+0.664
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
EOD3.2841.661+1.623
MRQ3.3791.264+2.115
TTM3.3791.265+2.114
YOY4.5431.435+3.108
5Y3.3281.483+1.845
10Y2.6631.612+1.051
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Biotest Aktiengesellschaft compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--3.2303.2300%-0.235+107%0.019+17170%1.801+79%
Book Value Per Share--12.60812.6080%9.378+34%10.962+15%9.520+32%
Current Ratio--1.9631.9630%4.757-59%4.289-54%3.797-48%
Debt To Asset Ratio--0.6460.6460%0.692-7%0.635+2%0.619+4%
Debt To Equity Ratio--1.8281.8280%2.242-18%1.772+3%1.671+9%
Dividend Per Share----0%0.020-100%0.016-100%0.023-100%
Eps--3.2093.2090%-0.801+125%-0.021+101%0.550+484%
Free Cash Flow Per Share---0.912-0.9120%-1.764+93%-1.019+12%-1.367+50%
Free Cash Flow To Equity Per Share---0.912-0.9120%-1.764+93%-1.019+12%-1.367+50%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--9.042--------
Intrinsic Value_10Y_min---5.133--------
Intrinsic Value_1Y_max---0.402--------
Intrinsic Value_1Y_min---0.901--------
Intrinsic Value_3Y_max---0.210--------
Intrinsic Value_3Y_min---2.388--------
Intrinsic Value_5Y_max--1.183--------
Intrinsic Value_5Y_min---3.514--------
Market Cap--1685743855.2001685743855.2000%1685743855.2000%1401225115.320+20%1116431766.730+51%
Net Profit Margin--0.1860.1860%-0.061+133%-0.015+108%0.036+417%
Operating Margin----0%-0%0.025-100%0.047-100%
Operating Ratio--1.4151.4150%1.774-20%1.716-18%1.689-16%
Pb Ratio3.284-3%3.3793.3790%4.543-26%3.328+2%2.663+27%
Pe Ratio12.900-3%13.27413.2740%-53.178+501%-53.275+501%-65.182+591%
Price Per Share41.400-3%42.60042.6000%42.6000%35.410+20%30.229+41%
Price To Free Cash Flow Ratio-45.381+3%-46.697-46.6970%-24.151-48%-0.379-99%-3.027-94%
Price To Total Gains Ratio12.819-3%13.19013.1900%-198.323+1604%-58.196+541%-40.207+405%
Quick Ratio--0.4040.4040%1.110-64%1.013-60%1.013-60%
Return On Assets--0.0900.0900%-0.026+129%-0.005+106%0.012+651%
Return On Equity--0.2550.2550%-0.085+134%-0.016+106%0.019+1245%
Total Gains Per Share--3.2303.2300%-0.215+107%0.035+9161%1.824+77%
Usd Book Value--533823000.000533823000.0000%397077000.000+34%464144600.000+15%451085250.000+18%
Usd Book Value Change Per Share--3.4563.4560%-0.251+107%0.020+17170%1.927+79%
Usd Book Value Per Share--13.49013.4900%10.034+34%11.729+15%10.187+32%
Usd Dividend Per Share----0%0.022-100%0.017-100%0.025-100%
Usd Eps--3.4343.4340%-0.857+125%-0.023+101%0.588+484%
Usd Free Cash Flow---38627000.000-38627000.0000%-74686000.000+93%-43142400.000+12%-61043500.000+58%
Usd Free Cash Flow Per Share---0.976-0.9760%-1.887+93%-1.090+12%-1.463+50%
Usd Free Cash Flow To Equity Per Share---0.976-0.9760%-1.887+93%-1.090+12%-1.463+50%
Usd Market Cap--1803745925.0641803745925.0640%1803745925.0640%1499310873.392+20%1194581990.401+51%
Usd Price Per Share44.298-3%45.58245.5820%45.5820%37.889+20%32.345+41%
Usd Profit--135890000.000135890000.0000%-33919000.000+125%-898800.000+101%17146750.000+693%
Usd Revenue--732522000.000732522000.0000%552227000.000+33%560594400.000+31%528459625.000+39%
Usd Total Gains Per Share--3.4563.4560%-0.230+107%0.037+9161%1.952+77%
 EOD+3 -3MRQTTM+0 -0YOY+25 -55Y+25 -1010Y+25 -10

3.2. Fundamental Score

Let's check the fundamental score of Biotest Aktiengesellschaft based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1512.900
Price to Book Ratio (EOD)Between0-13.284
Net Profit Margin (MRQ)Greater than00.186
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.404
Current Ratio (MRQ)Greater than11.963
Debt to Asset Ratio (MRQ)Less than10.646
Debt to Equity Ratio (MRQ)Less than11.828
Return on Equity (MRQ)Greater than0.150.255
Return on Assets (MRQ)Greater than0.050.090
Total6/10 (60.0%)

3.3. Technical Score

Let's check the technical score of Biotest Aktiengesellschaft based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose41.400
Total0/1 (0.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2019-12-312020-12-312021-12-312022-12-312023-12-31
Income before Tax  -1,300-28,700-30,000-32,600-62,60031,800-30,800137,100106,300
Net Income  -4,700-26,700-31,400-32,000-63,40031,700-31,700158,700127,000
Operating Income  -6,7004,200-2,500-49,600-52,10043,600-8,500128,600120,100
Tax Provision  3,400-2,0001,400-700700100800-21,500-20,700
Net Income from Continuing Operations  -4,700-26,700-31,400-32,000-63,40031,700-31,700158,700127,000



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in EUR. All numbers in thousands.

Summary
Total Assets1,410,900
Total Liabilities912,000
Total Stockholder Equity498,900
 As reported
Total Liabilities 912,000
Total Stockholder Equity+ 498,900
Total Assets = 1,410,900

Assets

Total Assets1,410,900
Total Current Assets756,500
Long-term Assets654,400
Total Current Assets
Cash And Cash Equivalents 108,100
Short-term Investments 10,400
Net Receivables 145,200
Inventory 419,100
Other Current Assets 2,700
Total Current Assets  (as reported)756,500
Total Current Assets  (calculated)685,500
+/- 71,000
Long-term Assets
Property Plant Equipment 578,400
Goodwill 6,000
Intangible Assets 9,000
Long-term Assets Other 100
Long-term Assets  (as reported)654,400
Long-term Assets  (calculated)593,500
+/- 60,900

Liabilities & Shareholders' Equity

Total Current Liabilities385,300
Long-term Liabilities526,700
Total Stockholder Equity498,900
Total Current Liabilities
Short Long Term Debt 226,800
Accounts payable 78,100
Other Current Liabilities 5,800
Total Current Liabilities  (as reported)385,300
Total Current Liabilities  (calculated)310,700
+/- 74,600
Long-term Liabilities
Long term Debt 329,500
Capital Lease Obligations Min Short Term Debt57,800
Long-term Liabilities Other -300
Long-term Liabilities  (as reported)526,700
Long-term Liabilities  (calculated)387,000
+/- 139,700
Total Stockholder Equity
Retained Earnings 239,500
Total Stockholder Equity (as reported)498,900
Total Stockholder Equity (calculated)239,500
+/- 259,400
Other
Capital Stock39,600
Common Stock Shares Outstanding 39,571
Net Debt 448,200
Net Invested Capital 1,055,200
Net Working Capital 371,200
Property Plant and Equipment Gross 962,400



Balance Sheet

Currency in EUR. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
> Total Assets 
932,800
978,500
1,042,300
1,108,400
1,131,300
1,104,200
1,203,000
1,410,900
1,410,9001,203,0001,104,2001,131,3001,108,4001,042,300978,500932,800
   > Total Current Assets 
467,200
449,700
495,100
522,800
556,300
522,200
619,400
756,500
756,500619,400522,200556,300522,800495,100449,700467,200
       Cash And Cash Equivalents 
72,900
22,300
61,900
60,800
71,300
104,400
116,600
108,100
108,100116,600104,40071,30060,80061,90022,30072,900
       Short-term Investments 
10,000
5,900
44,200
24,900
17,900
13,100
20,000
10,400
10,40020,00013,10017,90024,90044,2005,90010,000
       Net Receivables 
163,800
133,800
118,700
107,700
115,800
107,300
124,500
145,200
145,200124,500107,300115,800107,700118,700133,800163,800
       Inventory 
170,800
146,900
208,300
280,100
290,100
244,600
293,800
419,100
419,100293,800244,600290,100280,100208,300146,900170,800
       Other Current Assets 
1,400
1,300
400
1,400
1,200
3,100
2,900
2,700
2,7002,9003,1001,2001,4004001,3001,400
   > Long-term Assets 
465,600
528,800
547,200
585,600
575,000
582,000
583,600
654,400
654,400583,600582,000575,000585,600547,200528,800465,600
       Property Plant Equipment 
0
0
0
547,900
548,200
550,000
547,800
578,400
578,400547,800550,000548,200547,900000
       Goodwill 
16,800
7,300
7,200
7,200
7,100
7,100
7,200
6,000
6,0007,2007,1007,1007,2007,2007,30016,800
       Intangible Assets 
8,500
9,300
9,200
6,600
6,900
4,100
9,200
9,000
9,0009,2004,1006,9006,6009,2009,3008,500
       Long-term Assets Other 
400
100
547,200
100
100
400
100
100
100100400100100547,200100400
> Total Liabilities 
572,100
630,700
547,100
631,500
689,700
723,800
831,900
912,000
912,000831,900723,800689,700631,500547,100630,700572,100
   > Total Current Liabilities 
146,000
251,200
125,600
115,000
105,600
106,400
130,200
385,300
385,300130,200106,400105,600115,000125,600251,200146,000
       Short-term Debt 
16,000
119,400
500
3,300
0
0
0
0
00003,300500119,40016,000
       Short Long Term Debt 
16,000
119,400
500
3,300
1,400
1,600
4,800
226,800
226,8004,8001,6001,4003,300500119,40016,000
       Accounts payable 
62,800
65,000
73,400
52,200
42,000
38,800
51,100
78,100
78,10051,10038,80042,00052,20073,40065,00062,800
       Other Current Liabilities 
27,900
27,000
5,100
7,700
6,000
4,300
4,900
5,800
5,8004,9004,3006,0007,7005,10027,00027,900
   > Long-term Liabilities 
426,100
379,500
421,500
516,500
584,100
617,400
701,700
526,700
526,700701,700617,400584,100516,500421,500379,500426,100
       Long term Debt 
326,600
283,500
325,600
379,600
438,200
467,900
540,500
329,500
329,500540,500467,900438,200379,600325,600283,500326,600
       Capital Lease Obligations 
3,600
3,500
3,300
26,700
27,400
26,800
29,000
57,800
57,80029,00026,80027,40026,7003,3003,5003,600
       Long-term Liabilities Other 
1,900
1,300
-600
300
-600
-1,900
-700
-300
-300-700-1,900-600300-6001,3001,900
> Total Stockholder Equity
360,500
347,600
495,000
476,900
441,600
380,400
371,100
498,900
498,900371,100380,400441,600476,900495,000347,600360,500
   Common Stock00000000
   Retained Earnings 
101,100
88,200
235,600
217,500
182,200
121,000
111,700
239,500
239,500111,700121,000182,200217,500235,60088,200101,100
   Capital Surplus 00000000
   Treasury Stock00000000
   Other Stockholders Equity 00000000



Balance Sheet

Currency in EUR. All numbers in thousands.




Cash Flow

Currency in EUR. All numbers in thousands.




Income Statement

Currency in EUR. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue684,600
Cost of Revenue-404,300
Gross Profit280,300280,300
 
Operating Income (+$)
Gross Profit280,300
Operating Expense-564,500
Operating Income120,100-284,200
 
Operating Expense (+$)
Research Development66,800
Selling General Administrative81,000
Selling And Marketing Expenses0
Operating Expense564,500147,800
 
Net Interest Income (+$)
Interest Income2,000
Interest Expense-40,000
Other Finance Cost-200
Net Interest Income-38,200
 
Pretax Income (+$)
Operating Income120,100
Net Interest Income-38,200
Other Non-Operating Income Expenses0
Income Before Tax (EBT)106,300120,100
EBIT - interestExpense = -40,000
127,000
167,000
Interest Expense40,000
Earnings Before Interest and Taxes (EBIT)0146,300
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax106,300
Tax Provision--20,700
Net Income From Continuing Ops127,000127,000
Net Income127,000
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net038,200
 

Technical Analysis of Biotest Aktiengesellschaft
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Biotest Aktiengesellschaft. The general trend of Biotest Aktiengesellschaft is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Biotest Aktiengesellschaft's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Biotest Aktiengesellschaft.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 41.40 < 41.40 < 41.40.

The bearish price targets are: 41.20 > 41.00 > 41.00.

Tweet this
Biotest Aktiengesellschaft Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Biotest Aktiengesellschaft. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Biotest Aktiengesellschaft Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Biotest Aktiengesellschaft.

Biotest Aktiengesellschaft Daily Moving Average Convergence/Divergence (MACD) ChartBiotest Aktiengesellschaft Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Biotest Aktiengesellschaft. The current adx is .

Biotest Aktiengesellschaft Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Biotest Aktiengesellschaft.

Biotest Aktiengesellschaft Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Biotest Aktiengesellschaft.

Biotest Aktiengesellschaft Daily Relative Strength Index (RSI) ChartBiotest Aktiengesellschaft Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Biotest Aktiengesellschaft.

Biotest Aktiengesellschaft Daily Stochastic Oscillator ChartBiotest Aktiengesellschaft Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Biotest Aktiengesellschaft.

Biotest Aktiengesellschaft Daily Commodity Channel Index (CCI) ChartBiotest Aktiengesellschaft Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Biotest Aktiengesellschaft.

Biotest Aktiengesellschaft Daily Chande Momentum Oscillator (CMO) ChartBiotest Aktiengesellschaft Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Biotest Aktiengesellschaft.

Biotest Aktiengesellschaft Daily Williams %R ChartBiotest Aktiengesellschaft Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Biotest Aktiengesellschaft.

Biotest Aktiengesellschaft Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Biotest Aktiengesellschaft.

Biotest Aktiengesellschaft Daily Average True Range (ATR) ChartBiotest Aktiengesellschaft Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Biotest Aktiengesellschaft.

Biotest Aktiengesellschaft Daily On-Balance Volume (OBV) ChartBiotest Aktiengesellschaft Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Biotest Aktiengesellschaft.

Biotest Aktiengesellschaft Daily Money Flow Index (MFI) ChartBiotest Aktiengesellschaft Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Biotest Aktiengesellschaft.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-18CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-27CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-03SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-09SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-18SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-26CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-31STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-09STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-23SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-04CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-08MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-13CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-19MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-27MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-05WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-15CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

Biotest Aktiengesellschaft Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Biotest Aktiengesellschaft based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose41.400
Total0/1 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Biotest Aktiengesellschaft with someone you think should read this too:
  • Are you bullish or bearish on Biotest Aktiengesellschaft? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Biotest Aktiengesellschaft? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Biotest Aktiengesellschaft

I send you an email if I find something interesting about Biotest Aktiengesellschaft.


Comments

How you think about this?

Leave a comment

Stay informed about Biotest Aktiengesellschaft.

Receive notifications about Biotest Aktiengesellschaft in your mailbox!